Technical Analysis for AGIO - Agios Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 37.74 -1.07% -0.41
AGIO closed down 1.07 percent on Friday, September 13, 2019, on 1.65 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical AGIO trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish -1.07%
1,2,3 Retracement Bearish Bearish Swing Setup -1.07%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.07%
MACD Bullish Signal Line Cross Bullish -1.07%
Doji - Bearish? Reversal -1.07%
Wide Bands Range Expansion -1.07%

Older signals for AGIO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its products include AG-221, an oral inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that harbor IDH2 mutations, as well as for the Type II D-2 hydroxyglutaric aciduria treatment; AG-120, an oral inhibitor of the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations; and enzyme glutaminase that converts the nutrient glutamine into the metabolite glutamate. The company's products also comprise AG-348, an oral small molecule activator of PKR enzyme for the treatment of patients with pyruvate kinase deficiency. It has a collaboration agreement with Celgene Corporation. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Chemistry Biopharmaceutical Cancer Cancers Organic Chemistry Inborn Errors Of Metabolism Agios Pharmaceuticals
Is AGIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 79.17
52 Week Low 33.17
Average Volume 562,186
200-Day Moving Average 51.9542
50-Day Moving Average 42.2884
20-Day Moving Average 38.467
10-Day Moving Average 36.239
Average True Range 1.9251
ADX 31.21
+DI 18.8203
-DI 24.3749
Chandelier Exit (Long, 3 ATRs ) 38.3647
Chandelier Exit (Short, 3 ATRs ) 38.9453
Upper Bollinger Band 44.4247
Lower Bollinger Band 32.5093
Percent B (%b) 0.44
BandWidth 30.975641
MACD Line -1.7946
MACD Signal Line -2.0828
MACD Histogram 0.2882
Fundamentals Value
Market Cap 1.83 Billion
Num Shares 48.4 Million
EPS -6.33
Price-to-Earnings (P/E) Ratio -5.96
Price-to-Sales 59.19
Price-to-Book 6.21
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.44
Resistance 3 (R3) 40.38 39.43 39.99
Resistance 2 (R2) 39.43 38.74 39.46 39.84
Resistance 1 (R1) 38.58 38.31 38.11 38.64 39.69
Pivot Point 37.63 37.63 37.39 37.66 37.63
Support 1 (S1) 36.78 36.94 36.31 36.84 35.79
Support 2 (S2) 35.83 36.51 35.86 35.64
Support 3 (S3) 34.98 35.83 35.49
Support 4 (S4) 35.04